Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. An intravenous Fe3O4 preparation for treatment of anaemia resulting from chronic kidney disease.

Etymologies

Sorry, no etymologies found.

Examples

  • The Cambridge, Mass., biopharmaceutical company received a letter from the Food and Drug Administration asking for more information on its iron-replacement drug ferumoxytol.

    Laclede, New Jersey Resources Gain Strongly

  • Feraheme® (ferumoxytol) Injection for intravenous (IV) use.

    AMAG Pharmaceuticals Provides Business Update - Yahoo! Finance

  • AMAG manufactures and sells Feraheme® ferumoxytol Injection for intravenous use.

    AMAG Pharmaceuticals Provides Business Update - Yahoo! Finance

  • (NASDAQ: AMAG - News) will host a conference call and webcast today at 8: 00 am ET to discuss today's announcement that AMAG Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company have entered into a strategic collaboration agreement related to Feraheme® (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications in select ex-US territories.

    BioSpace.com Featured News and Stories

  • (NASDAQ: AMAG) will host a conference call and webcast at 8: 00 am ET to discuss AMAG Pharmaceutical, Inc. and Takeda Pharmaceuticals Company have entered into a strategic collaboration agreement related to Feraheme (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications in select ex-US territories.

    American Chronicle

  • (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today jointly announced that the companies have entered into a license, development and commercialization agreement related to Feraheme® (ferumoxytol) Injection for intravenous (IV) use in all therapeutic indications.

    The Earth Times Online Newspaper

  • Food and Drug Administration to market Feraheme® (ferumoxytol) Injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

    The Earth Times Online Newspaper

  • Food and Drug Administration to market Feraheme (R) (ferumoxytol) Injection for intravenous (IV) use for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

    TradingMarkets

  • Food and Drug Administration to market Feraheme® (ferumoxytol) Injection for the treatment of iron deficiency anemia in adult chronic kidney disease patients.

    BioSpace.com Featured News and Stories

  • -- (BUSINESS WIRE) -- AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.

    BioSpace.com Featured News and Stories

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.